Learning disability end-of-life researcher joins Faculty of Health, Social Care and Education

An expert in the palliative care of people with learning disabilities has taken up a new role at Kingston University and St George’s, University of London.

Dr Irene Tuffrey-Wijne has been appointed a senior research fellow at the Faculty of Health, Social Care and Education, run jointly by Kingston and St George’s.

Fully funded postgraduate course available to NHS professionals interested in clinical research

Eighteen fully funded studentships in London are being offered to NHS healthcare professionals this year to equip them for careers in clinical research.

The Master of Research in Clinical Practice (MResCP) is aimed at nurses, midwives and allied health professionals, to give them the skills to manage and deliver research in a clinical setting. It is being run by Kingston University and St George’s, University of London, and is now recruiting for September 2013 entry. Applications must be received by Friday 17 May.

Dogma among researchers exaggerates threat of resistance to best anti-malarial drugs, says expert on World Malaria Day 2013 (25 April)

Exaggeration over the extent of the malaria parasite’s resistance to the ‘wonder drugs’ artemisinins could jeopardise the fight against the disease, according to a leading expert.

In an opinion article published on World Malaria Day today (25 April 2013) – online in the journal Trends in Parasitology – Professor Sanjeev Krishna of St George’s, University of London argues that much of the evidence of the malaria parasite’s resistance to artemisinins has been misinterpreted. He says this has led to the extent of artemisinin resistance being overstated, and that fears of its demise as an effective treatment are premature.

Malaria parasite protein identified as potential new target for drug treatment

Scientists have discovered how a protein within the malaria parasite is essential to its survival as it develops inside a mosquito. They believe their findings identify this protein as a potential new target for drug treatments to prevent malaria being passed to humans.

The researchers found that when this protein – a transporter responsible for controlling the level of calcium inside cells – is absent during the parasite’s sexual reproduction stages inside a mosquito, the parasite dies before developing fully. They discovered that the calcium transporter protein is responsible for protecting the parasite from potentially lethal levels of calcium during these stages.

Nanomal smartphone-like malaria detection device to be field tested one year earlier than scheduled

A pioneering mobile device using cutting-edge nanotechnology to rapidly detect malaria infection and drug resistance will be ready for field testing this year, one year ahead of schedule.

The €5.2million (£4million) Nanomal project was launched last year to provide an affordable hand-held diagnostic device to detect malaria infection and parasites’ drug resistance in 15 minutes. It will allow healthcare workers in remote rural areas to deliver effective drug treatments to counter resistance more quickly, potentially saving lives.